Cancer risk associated with anti-TIF1 antibodies

被引:0
|
作者
Collison J.
机构
[1] Nature Reviews Rheumatology,
关键词
D O I
10.1038/s41584-019-0164-3
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:64 / 64
相关论文
共 50 条
  • [41] Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria
    Didona, Dario
    Juratli, Hazem A.
    Scarsella, Luca
    Keber, Ursula
    Eming, Ruediger
    Hertl, Michael
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (03) : 279 - 288
  • [42] Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies
    Ueda-Hayakawa, Ikuko
    Tonomura, Kyoko
    Maekawa, Aya
    Kaneda, Emi
    Arase, Noriko
    Fujimoto, Manabu
    JOURNAL OF DERMATOLOGY, 2023, 50 (08): : 1058 - 1062
  • [43] Anti-TIF-1 Antibody Positivity Is Associated with a Five-Fold Increase in Cancer Risk in the Idiopathic Inflammatory Myopathies
    Oldroyd, Alexander
    Sergeant, Jamie C.
    New, Paul
    McHugh, Neil J.
    Betteridge, Zoe
    Lamb, Janine
    Ollier, William
    Cooper, Robert
    Chinoy, Hector
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] ANTI-TIF-1 ANTIBODY POSITIVITY IS ASSOCIATED WITH A FIVE-FOLD INCREASE IN CANCER RISK IN THE IDIOPATHIC INFLAMMATORY MYOPATHIES
    Oldroyd, Alexander
    Sergeant, Jamie
    New, Paul
    McHugh, Neil
    Betteridge, Zoe
    Lamb, Janine
    Ollier, William
    Cooper, Robert
    Chinoy, Hector
    RHEUMATOLOGY, 2018, 57
  • [45] Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review
    Sakurai, Takuya
    Takahashi, Junichiro
    Komatsu, Teppei
    Mitsumura, Hidetaka
    Iguchi, Yasuyuki
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (02) : 416 - 421
  • [46] Cutaneous features of anti-TIF1-γ-associated dermatomyositis
    Ho, Benjamin Wen Yang
    Wang, Ding Yuan
    CLINICAL RHEUMATOLOGY, 2021, 40 (03) : 1191 - 1192
  • [47] Cutaneous features of anti-TIF1-γ-associated dermatomyositis
    Benjamin Wen Yang Ho
    Ding Yuan Wang
    Clinical Rheumatology, 2021, 40 : 1191 - 1192
  • [48] Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis
    McMorrow, Fionnuala K.
    Wedderburn, Lucy R.
    Chinoy, Hector
    Oldroyd, Alexander
    Lamb, Janine A.
    Rider, Lisa G.
    Mammen, Andrew L.
    Casciola-Rosen, Livia
    McHugh, Neil J.
    Tansley, Sarah L.
    RHEUMATOLOGY, 2024,
  • [49] ANTIBODIES AGAINST TIF1GAMMA IN CANCER ASSOCIATED MYOSITIS PRECEDE CANCER SYMPTOMS AND PERSIST AFTER CANCER REMOVAL
    Dani, L.
    Dastmalchi, M.
    Martinez, N.
    Labrador-Horrillo, M.
    Selva-O'Callaghan, A.
    Lundberg, I. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 644 - 644
  • [50] Anti-TIF1 gamma-positive IPAF patient developed stage IVB lung squamous carcinoma in 1 year: a case report
    Jiao-jiao Xie
    Bin Li
    Rui Xu
    Xian-zhi Du
    Jin-zhi He
    BMC Pulmonary Medicine, 21